The BOI, in order to support developing new industry verticals via import substitution and exports, is establishing a state-of-the-art pharmaceutical zone in Arabokka, Hambantota. This dedicated Pharmaceutical Manufacturing Zone plans to meet 40% of the domestic demand for pharmaceutical products by locally manufactured drugs while creating a pathway to export earnings as import substitution by 2025. The Zone will be declared as a “Strategic Development Project” (SDP) and strategic pharmaceutical investments established within the proposed zone will be eligible for benefits under the SDP Act. This State–of–Art zone will be designed to International standards and accreditations. This specifically tailored zone will make a conducive and liveable business environment to globally renewed pharmaceutical brands to bring the latest technological advances to manufacture pharmaceutical products.